Practimed
ActiveSummary
Practimed has been active since 1965 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €35.0m and a net result of €2.4m. Equity remains stable across the filed financial years (±1.7% per year). Its solvency ranks better than 75% of 779 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Activity
Specialist medical practice
NACE 86220Medical imaging and medical laboratories NACE 86910
Largest company by total assets in Tessenderlo-Ham, Health and social work sector4 sites
Size
€29.2mturnover 2025
- Staff
- 132.4 FTE
- Equity
- €35.0m
- Profit
- €2.4m
Structure
- Parent
- DR. T. LEBON · 99.9%
- Board
- 8 members
- Holdings
- 1
- Dr.Daisy TimmermansChair
- Dr.Ben JanssenManaging director
Auditor: Figurad Bedrijfsrevisoren bvAccounts 27 days early7 of 20 deeds read
Why 96raises riskLiquidity: current ratio 3.89, cash €650,5891 of the last 3 latelowers riskSize: turnover €29.2m, 132.4 FTE, total assets €44.1mSector: Human health activities (NACE 86)Show the evidence
Checked score
Score 2025
96
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 72% of its sector peers (NACE 86, medium-sized)
Financial strength · tick = 2024
Strong
Solvency
100=
equity 79.5% of total assets
Liquidity
51+1
short-term debt 11.4% · cash 1.5%
Profitability
82+2
return on assets 5.5%
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.2%
12-2024: 0.2%● unchanged vs 11-2024
01-2025: 0.2%● unchanged vs 12-2024
02-2025: 0.2%● unchanged vs 01-2025
03-2025: 0.2%● unchanged vs 02-2025
04-2025: 0.2%● unchanged vs 03-2025
05-2025: 0.2%● unchanged vs 04-2025
06-2025: 0.2%● unchanged vs 05-2025
07-2025: 0.3%▲ +0.1 percentage points vs 06-2025highest value
08-2025: 0.1%▼ -0.2 percentage points vs 07-2025
09-2025: 0.1%● unchanged vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026
08-2026: 0.1%● unchanged vs 07-2026lowest value
09-2026: 0.1%● unchanged vs 08-2026lowest value
10-2026: 0.1%● unchanged vs 09-2026lowest value
Credit of up to €2,900,000 on 30-day terms is acceptable
Liquidity ample (current ratio 3.89, compared with 3.44 in 2024, above the usual 1.5; short-term debt: 11.4% and cash: 1.5% of total assets), and 20.5% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, medium-sized): better than 92% on solvency, 46% on liquidity, 81% on profitability and 67% on growth.
The bankruptcy probability was computed on 21-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 04-07-2026, 27 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
27 days early
2024
31 days early
2023
282 days late
2022
66 days early
2021
66 days early
2020
65 days early
2019
66 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 6 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 June (4 of the last 5 filed years within 35 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
22-10-2026 today31-12-2026 year end31-07-2027 deadline
- Annual accounts filedfinancial year 2025 · full…
- Appointment: Frederik RAEMDONCK (gedelegeerde voor het…Gazette deed
- Capital & shares · Amendment of…Capital increase · Capital decrease…
Financials · financial year 2025, full format
In the rankings
#1 company by total assets in Tessenderlo-Ham, Health and social work sector#1 company by equity in Tessenderlo-Ham, Health and social work sector#1 oldest company in Tessenderlo-Ham, Health and social work sector
Turnover
€29.2m▲ 6.6%
2024 · €27.4m
EBIT margin
10.3%▲ 1.3pp
2024 · 9.0%
Net result
€2.4m▼ 5.6%
2024 · €2.6m
Working capital
€14.6m▲ 19.9%
2024 · €12.1m
Trend over the years
2021 to 2025, 5 financial years 2018 to 2025, 8 financial years
The operating result recovers in 2025; 2025 is 22% above 2024.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
Turnover€29.2m
2025
Operating result€3.0m
2025
Net result€2.4m
2025
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Total assets€44.1m
2025
Equity€35.0m
2025
Debt€9.0m
2025
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
Working capital€14.6m
2025
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
EBIT margin10.3%
2025
Return on assets (ROA)5.5%
2025
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Solvency79.5%
2025
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Current ratio3.89
2025
Average staff in full-time equivalents (FTE).
Staff (FTE)132.4
2025
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
Every figure with its change against the financial year before
favourable
unfavourable
Line20182019202020212022202320242025
Turnover€18.0m-€18.9m▲ 4.5%€19.5m▲ 3.4%€27.3m▲ 40.1%€26.0m▼ 5.0%€27.0m▲ 3.9%€27.4m▲ 1.4%€29.2m▲ 6.6%
Operating result€3.7m-€3.6m▼ 2.4%€2.8m▼ 22.1%€6.7m▲ 136%€3.9m▼ 41.5%€3.0m▼ 22.4%€2.5m▼ 18.7%€3.0m▲ 22.1%
Net result€2.3m-€2.9m▲ 24.0%€2.6mabove the sector's middle half▼ 11.8%€5.3mabove the sector's middle half▲ 108%€2.6mabove the sector's middle half▼ 51.0%€2.7mabove the sector's middle half▲ 1.6%€2.6mabove the sector's middle half▼ 3.0%€2.4mabove the sector's middle half▼ 5.6%
EBIT margin20.6%-19.3%▼ 1.4pp14.5%▼ 4.8pp24.4%▲ 9.9pp15.0%▼ 9.4pp11.2%▼ 3.8pp9.0%▼ 2.2pp10.3%▲ 1.3pp
Equity€30.0m-€31.6m▲ 5.5%€32.0mabove the sector's middle half▲ 1.2%€34.3mabove the sector's middle half▲ 7.3%€32.2mabove the sector's middle half▼ 6.1%€33.6mabove the sector's middle half▲ 4.3%€32.3mabove the sector's middle half▼ 3.9%€35.0mabove the sector's middle half▲ 8.5%
Total assets€31.7m-€39.4m▲ 24.5%€40.0mabove the sector's middle half▲ 1.5%€43.0mabove the sector's middle half▲ 7.4%€45.9mabove the sector's middle half▲ 6.7%€45.8mabove the sector's middle half▼ 0.1%€42.7mabove the sector's middle half▼ 6.8%€44.1mabove the sector's middle half▲ 3.2%
Debt€1.7m-€7.8m▲ 357%€8.0m▲ 2.6%€8.7m▲ 8.1%€13.6m▲ 57.4%€12.2m▼ 10.7%€10.4m▼ 14.7%€9.0m▼ 13.2%
Working capital€20.7m-€21.1m▲ 2.1%€21.0mabove the sector's middle half▼ 0.3%€23.2mabove the sector's middle half▲ 10.5%€16.0mabove the sector's middle half▼ 31.0%€14.9mabove the sector's middle half▼ 7.0%€12.1mabove the sector's middle half▼ 18.5%€14.6mabove the sector's middle half▲ 19.9%
Solvency94.6%-80.2%▼ 14.4pp80.0%above the sector's middle half▼ 0.2pp79.8%above the sector's middle half▼ 0.1pp70.3%within the sector's middle half▼ 9.6pp73.4%within the sector's middle half▲ 3.1pp75.7%within the sector's middle half▲ 2.3pp79.5%above the sector's middle half▲ 3.9pp
Current ratio13.92-11.46▼ 2.468.99above the sector's middle half▼ 2.477.43above the sector's middle half▼ 1.563.84within the sector's middle half▼ 3.603.81within the sector's middle half▼ 0.023.44within the sector's middle half▼ 0.383.89within the sector's middle half▲ 0.45
Return on assets (ROA)7.4%-7.4%=6.4%within the sector's middle half▼ 1.0pp12.4%within the sector's middle half▲ 6.0pp5.7%within the sector's middle half▼ 6.7pp5.8%within the sector's middle half▲ 0.1pp6.0%within the sector's middle half▲ 0.2pp5.5%within the sector's middle half▼ 0.5pp
Staff (FTE)89.6-94.9▲ 5.9%102.5above the sector's middle half▲ 8.0%115.5above the sector's middle half▲ 12.7%130.2above the sector's middle half▲ 12.7%134.3above the sector's middle half▲ 3.1%132.4above the sector's middle half▼ 1.4%132.4above the sector's middle half=
above
within
below
the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €44.1m
Fixed assets
€24.5m ▼ 4.3%
Current assets
€19.6m ▲ 14.5%
Equity and liabilities €44.1m
Equity
€35.0m ▲ 8.5%
Debt
€9.0m ▼ 13.2%
Debt's share of the balance-sheet total falls from 24.3% to 20.5%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€5.4m▲
2024 · €4.7m
Cash flow
€4.9m▲
2024 · €4.8m
Quick ratio
3.69▲
2024 · 3.27
Debt to equity
0.26▼
2024 · 0.32
ROE
6.9%▼
2024 · 8.0%
Interest coverage
84.71▲
2024 · 55.88
Debt ≤ 1 year
€5.0m▲
2024 · €5.0m
Debt > 1 year
€4.0m▼
2024 · €5.4m
Income taxes
€946,823▲
2024 · €849,219
Staff costs
€10.5m▲
2024 · €9.9m
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 1,579 companies that looked in July 2024 the way this one looks now, 0.1% went bankrupt within 24 months and 96.7% are still going.
- Medium-sized
- 20 years or older
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.1%
went bankrupt
3.2%
stopped otherwise
96.7%
still going
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,473 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 1,579 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Operating income70/76A | - | - | - | €28.2m | €26.9m | €27.9m | €28.5m | €30.5m | ▲ 7.2% |
| Turnover70 | €18.0m | €18.9m | €19.5m | €27.3m | €26.0m | €27.0m | €27.4m | €29.2m | ▲ 6.6% |
| Other operating income74 | - | - | - | €0.9m | €0.9m | €0.9m | €1.1m | €1.4m | ▲ 21.8% |
| Operating charges60/66A | - | - | - | €21.5m | €23.0m | €24.9m | €26.0m | €27.5m | ▲ 5.8% |
| Goods for resale, raw materials and consumables60 | - | - | - | €5.3m | €4.7m | €4.3m | €4.5m | €4.7m | ▲ 5.1% |
| Purchases600/8 | - | - | - | €5.4m | €4.4m | €4.3m | €4.4m | €4.8m | ▲ 9.1% |
| Change in stocks: decrease (increase)609 | - | - | - | -€0.1m | €0.3m | -€0.01m | €0.04m | -€0.1m | - |
| Services and other goods61 | - | - | - | €6.7m | €7.8m | €9.1m | €9.2m | €9.8m | ▲ 6.0% |
| Remuneration, social security and pensions62 | - | - | - | €7.8m | €8.8m | €9.6m | €9.9m | €10.5m | ▲ 6.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1.3m | €1.4m | €1.5m | €1.6m | €1.6m | €1.8m | €2.2m | €2.4m | ▲ 8.6% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | - | - | - | €0.03m | -€0.08m | -€0.01m | -€0.007m | -€0.04m | ▼ 450% |
| Other operating charges640/8 | - | - | - | €0.1m | €0.2m | €0.1m | €0.2m | €0.1m | ▼ 27.1% |
| Operating profit (loss)9901 | €3.7m | €3.6m | €2.8m | €6.7m | €3.9m | €3.0m | €2.5m | €3.0m | ▲ 22.1% |
| Financial income75/76B | - | - | - | €0.8m | €0.3m | €0.7m | €1.2m | €0.4m | ▼ 62.0% |
| Recurring financial income75 | €0.2m | €0.3m | €0.8m | €0.8m | €0.3m | €0.7m | €1.2m | €0.4m | ▼ 62.0% |
| Income from current assets751 | - | - | - | €0.8m | €0.3m | €0.5m | €1.1m | €0.4m | ▼ 64.2% |
| Other financial income752/9 | - | - | - | €0.001m | €0.07m | €0.2m | €0.06m | €0.05m | ▼ 18.9% |
| Financial charges65/66B | - | - | - | €0.1m | €0.5m | €0.2m | €0.2m | €0.07m | ▼ 66.2% |
| Recurring financial charges65 | €0.3m | -€0.1m | €0.2m | €0.1m | €0.5m | €0.2m | €0.2m | €0.07m | ▼ 66.2% |
| Debt charges650 | €0.002m | €0.05m | €0.06m | €0.05m | €0.06m | €0.1m | €0.08m | €0.06m | ▼ 23.7% |
| Write-downs on current assets other than stocks, contracts in progress and trade receivables: additions (reversals)651 | - | - | - | - | - | - | - | -€0.07m | - |
| Other financial charges652/9 | - | - | - | €0.09m | €0.5m | €0.07m | €0.1m | €0.07m | ▼ 36.4% |
| Profit (loss) for the period before taxes9903 | €3.5m | €4.1m | €3.4m | €7.4m | €3.7m | €3.5m | €3.4m | €3.4m | ▼ 1.4% |
| Income taxes67/77 | €1.2m | €1.1m | €0.9m | €2.0m | €1.1m | €0.9m | €0.8m | €0.9m | ▲ 11.5% |
| Taxes670/3 | - | - | - | €2.0m | €1.1m | €0.9m | €0.8m | €0.9m | ▲ 11.5% |
| Tax adjustments and reversals of tax provisions77 | - | - | - | - | - | €0.03m | - | - | - |
| Profit (loss) for the period9904 | €2.3m | €2.9m | €2.6m | €5.3m | €2.6m | €2.7m | €2.6m | €2.4m | ▼ 5.6% |
| Transfer from tax-exempt reserves789 | - | - | - | - | - | €0.1m | €0.1m | €0.7m | ▲ 550% |
| Transfer to tax-exempt reserves689 | - | - | - | €0.5m | €0.1m | €0.1m | €0 | €0.2m | - |
| Profit (loss) for the period to be appropriated9905 | €2.2m | €2.8m | €2.4m | €4.8m | €2.5m | €2.7m | €2.7m | €2.9m | ▲ 8.3% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €31.7m | €39.4m | €40.0m | €43.0m | €45.9m | €45.8m | €42.7m | €44.1m | ▲ 3.2% |
| Fixed assets21/28 | €9.4m | €16.3m | €16.3m | €16.1m | €24.2m | €25.6m | €25.6m | €24.5m | ▼ 4.3% |
| Intangible fixed assets21 | €0.2m | €0.4m | €0.4m | €0.6m | €0.4m | €0.6m | €0.6m | €0.6m | ▲ 5.1% |
| Tangible fixed assets22/27 | €8.9m | €15.6m | €15.6m | €15.2m | €23.4m | €24.7m | €24.7m | €23.5m | ▼ 4.6% |
| Land and buildings22 | - | - | - | €7.0m | €7.0m | €15.3m | €14.7m | €14.1m | ▼ 3.9% |
| Plant, machinery and equipment23 | - | - | - | €1.5m | €2.4m | €2.9m | €3.6m | €3.3m | ▼ 9.1% |
| Furniture and vehicles24 | - | - | - | €0.6m | €0.8m | €1.0m | €1.1m | €1.0m | ▼ 1.6% |
| Leasing and similar rights25 | - | - | - | €5.9m | €5.7m | €5.5m | €5.3m | €5.1m | ▼ 4.1% |
| Assets under construction and advance payments27 | - | - | - | €0.2m | €7.6m | €0 | - | - | - |
| Financial fixed assets28 | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | = |
| Affiliated companies280/1 | - | - | - | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | = |
| Participating interests280 | - | - | - | €0.3m | €0.3m | €0.3m | €0.3m | €0.3m | = |
| Other financial fixed assets284/8 | - | - | - | €0.001m | €0.001m | €0.001m | €0.001m | €0.001m | = |
| Amounts receivable and cash guarantees285/8 | - | - | - | €0.001m | €0.001m | €0.001m | €0.001m | €0.001m | = |
| Current assets29/58 | €22.2m | €23.1m | €23.7m | €26.8m | €21.7m | €20.2m | €17.1m | €19.6m | ▲ 14.5% |
| Stocks and contracts in progress3 | €0.6m | €0.7m | €1.1m | €1.2m | €0.9m | €0.9m | €0.9m | €1.0m | ▲ 15.5% |
| Stocks30/36 | - | - | - | €1.2m | €0.9m | €0.9m | €0.9m | €1.0m | ▲ 15.5% |
| Raw materials and consumables30/31 | - | - | - | €1.2m | €0.9m | €0.9m | €0.9m | €1.0m | ▲ 15.5% |
| Amounts receivable within one year40/41 | €2.2m | €2.2m | €2.9m | €7.2m | €3.6m | €3.5m | €3.7m | €4.5m | ▲ 21.2% |
| Trade receivables40 | - | - | - | €7.2m | €3.4m | €3.3m | €3.5m | €4.1m | ▲ 18.3% |
| Other amounts receivable41 | - | - | - | €0.007m | €0.3m | €0.2m | €0.2m | €0.3m | ▲ 73.6% |
| Current investments50/53 | €18.4m | €19.2m | €18.9m | €18.1m | €16.5m | €14.8m | €11.8m | €12.9m | ▲ 9.3% |
| Other investments51/53 | - | - | - | €18.1m | €16.5m | €14.8m | €11.8m | €12.9m | ▲ 9.3% |
| Cash at bank and in hand54/58 | €1.0m | €0.9m | €0.5m | €0.1m | €0.3m | €0.3m | €0.3m | €0.7m | ▲ 137% |
| Deferred charges and accrued income490/1 | - | - | - | €0.2m | €0.3m | €0.6m | €0.5m | €0.6m | ▲ 18.3% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €31.7m | €39.4m | €40.0m | €43.0m | €45.9m | €45.8m | €42.7m | €44.1m | ▲ 3.2% |
| Equity10/15 | €30.0m | €31.6m | €32.0m | €34.3m | €32.2m | €33.6m | €32.3m | €35.0m | ▲ 8.5% |
| Contributions10/11 | €3.2m | €3.5m | €3.4m | €3.6m | €3.5m | €3.9m | €3.7m | €4.3m | ▲ 13.8% |
| Capital10 | - | - | - | €3.6m | €3.5m | €3.9m | - | - | - |
| Issued capital100 | - | - | - | €3.6m | €3.5m | €4.0m | - | - | - |
| Uncalled capital101 | - | - | - | €0.005m | €0.007m | €0.03m | - | - | - |
| Reserves13 | €26.8m | €28.1m | €28.6m | €29.5m | €27.3m | €28.0m | €26.5m | €28.4m | ▲ 7.3% |
| Non-distributable reserves130/1 | - | - | - | €0.02m | €0.02m | €0.02m | €0.02m | €0.02m | = |
| Legal reserve130 | - | - | - | €0.02m | €0.02m | €0.02m | - | - | - |
| Reserves not available under the articles1311 | - | - | - | - | - | - | €0.02m | €0.02m | = |
| Tax-exempt reserves132 | - | - | - | €1.1m | €1.2m | €1.2m | €1.1m | €0.6m | ▼ 45.0% |
| Distributable reserves133 | - | - | - | €28.3m | €26.1m | €26.8m | €25.4m | €27.8m | ▲ 9.5% |
| Profit (loss) carried forward14 | €0.005m | €0.03m | €0.04m | €1.3m | €1.4m | €1.7m | €2.1m | €2.4m | ▲ 14.1% |
| Amounts payable17/49 | €1.7m | €7.8m | €8.0m | €8.7m | €13.6m | €12.2m | €10.4m | €9.0m | ▼ 13.2% |
| Amounts payable after more than one year17 | €0.1m | €5.8m | €5.4m | €5.0m | €8.0m | €6.8m | €5.4m | €4.0m | ▼ 26.8% |
| Financial debts170/4 | - | - | - | €5.0m | €8.0m | €6.8m | €5.4m | €4.0m | ▼ 26.8% |
| Leasing and similar obligations172 | - | - | - | €5.0m | €4.6m | €4.2m | €3.8m | €3.4m | ▼ 11.4% |
| Credit institutions173 | - | - | - | - | €3.3m | €2.6m | €1.6m | €0.6m | ▼ 62.9% |
| Amounts payable within one year42/48 | €1.6m | €2.0m | €2.6m | €3.6m | €5.7m | €5.3m | €5.0m | €5.0m | ▲ 1.3% |
| Current portion of amounts payable after more than one year42 | - | - | - | €0.4m | €1.5m | €1.5m | €1.5m | €1.4m | ▼ 5.9% |
| Trade debts44 | €0.6m | €0.6m | €1.0m | €1.2m | €2.4m | €1.7m | €1.8m | €1.8m | ▲ 4.2% |
| Suppliers440/4 | - | - | - | €1.2m | €2.4m | €1.7m | €1.8m | €1.8m | ▲ 4.2% |
| Taxes, remuneration and social security45 | - | - | - | €1.9m | €1.6m | €2.0m | €1.7m | €1.7m | ▼ 0.1% |
| Taxes450/3 | - | - | - | €0.3m | €0.4m | €0.6m | €0.3m | €0.5m | ▲ 74.0% |
| Remuneration and social security454/9 | - | - | - | €1.5m | €1.2m | €1.4m | €1.4m | €1.2m | ▼ 14.3% |
| Other amounts payable47/48 | - | - | - | €0.1m | €0.09m | €0.04m | €0.03m | €0.1m | ▲ 296% |
| Accrued charges and deferred income492/3 | - | - | - | €0.006m | €0.009m | €0.06m | €0.01m | €0.02m | ▲ 122% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €2.3m | €2.9m | €2.6m | €5.3m | €2.6m | €2.7m | €2.6m | €2.4m | ▼ 5.6% |
| + Depreciation and write-downs630 | €1.3m | €1.4m | €1.5m | €1.6m | €1.6m | €1.8m | €2.2m | €2.4m | ▲ 8.6% |
| Operating cash flow (approximation) | €3.6m | €4.3m | €4.1m | €6.9m | €4.2m | €4.4m | €4.8m | €4.9m | ▲ 1.0% |
| Investment in fixed assets (approximation) | - | -€8.3m | -€1.5m | -€1.4m | -€9.6m | -€3.2m | -€2.2m | -€1.3m | ▲ 39.7% |
| Change in cash | - | -€0.1m | -€0.4m | -€0.4m | €0.2m | €0.006m | -€0.07m | €0.4m | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Latest 10 of 49 filings with the National Bank
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | full format | 04-07-2026 | 2026-00264899 |
| 31-12-2024 | full format | 30-06-2025 | 2025-00219400 |
| 31-12-2023 | full format | 09-05-2025 | 2025-00092647 |
| 31-12-2022 | full format | 26-05-2023 | 2023-00094952 |
| 31-12-2021 | full format | 26-05-2022 | 2022-20036227 |
| 31-12-2020 | full format | 27-05-2021 | 2021-15600136 |
| 31-12-2019 | full format | 26-05-2020 | 2020-13500030 |
| 31-12-2018 | full format | 24-06-2019 | 2019-21800183 |
| 31-12-2017 | full format | 09-08-2018 | 2018-44700035 |
| 31-12-2016 | full format | 12-07-2017 | 2017-31000420 |
Similar companies · same sector, comparable size
Sociaal-Medisch Instituut der Zuiderkempen
BE 0403.621.057
Heist-op-den-Berg · equity €27.7m
L'ESPERANDERIE
BE 0402.481.407
Péruwelz · equity €24.6m
Medizorg
BE 0420.397.307
Merelbeke-Melle · equity €56.4m
BELRO MEDICAL
BE 0453.278.228
Waterloo · equity €15.9m
DOKTER F. GOES JR.
BE 0465.122.324
Schilde · equity €15.4m
Of the 16,579 active companies whose main activity is specialist medical practice (NACE 86220), figures are known for 8,110. 72 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector
Subsidies and aid
Flemish government
2022 to 2025 · 15 entries · €167,790 awarded · €110,429 paid| Year | Entries | Awarded | Paid |
|---|---|---|---|
| 2025 | 4 | €20,867 | €21,287 |
| 2024 | 4 | €100,519 | €42,738 |
| 2023 | 4 | €21,277 | €21,277 |
| 2022 | 3 | €25,127 | €25,127 |
Schemes
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Directors
8 directors, 2 in day-to-day management, last change in 2026
Board 8
Dr.Daisy Timmermans
CurrentVoorzitter van het bestuursorgaan · since 18-08-2025 · Director · since 18-08-2025
Dr.Ben Janssen
CurrentDirector · since 18-08-2025
Dr.Benoit Gielen
CurrentDirector · since 18-08-2025
Dr.Georges-Philippe Claes
CurrentDirector · since 18-08-2025
Dr.IIs Laeveren
CurrentDirector · since 18-08-2025
Dr.Joyce Van Hoeck
CurrentDirector · since 18-08-2025
Dr.Raf Verlinden
CurrentDirector · since 18-08-2025
Dr.Tom Germeys
CurrentDirector · since 18-08-2025
Day-to-day management 2
Dr.Ben Janssen
CurrentManaging director · since 18-08-2025
Frederik RAEMDONCK
CurrentGedelegeerde voor het dagelijks bestuur · since 15-01-2026
Statutory auditor 1
Figurad Bedrijfsrevisoren bv
CurrentStatutory auditor · since 07-06-2024 · permanent representative: Bart Meganck
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
13 of this company's 20 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.
Mandate history
14 people since 2024, 10 in office
- Board
- Day-to-day management
- Statutory auditor
- began earlier
| Name | Functions and periods |
|---|---|
| Dr.Ben Janssen |
|
| Dr.Benoit Gielen |
|
| Dr.Daisy Timmermans |
|
| Dr.Georges-Philippe Claes |
|
| Dr.IIs Laeveren |
|
| Dr.Joyce Van Hoeck |
|
| Dr.Raf Verlinden |
|
| Dr.Tom Germeys |
|
| Frederik RAEMDONCK |
|
| Figurad Bedrijfsrevisoren bv |
|
| Dr.Ans Mentens |
|
| Dr.Els Demoitié |
|
| Dr.Jean Boelanders |
|
| Dr.Lies Vanderperre |
|
Owners and capital
Owners
3 ownersChain of control
- DR. T. LEBON
- Practimed
Highest known parent: DR. T. LEBON. The sources do not say who stands above it.
Owners 3
- DR. T. LEBONparent99.9%
-
0.11%
-
0%
According to the 2021 annual accounts of Practimed and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Capital and shareholders
Capital over the years
- 22-12-2025 Capital increase of €548,545 · 17,695 new shares · “uitgifte van nieuwe aandelen”
- 22-12-2025 Capital reduction of €80,290
- 24-12-2024 Capital increase of €142,910 · 4,610 new shares
- 24-12-2024 Capital reduction of €308,388 · uittreding artikel 11 statuten
Group and network
Holdings and subsidiaries
1 holdingHoldings 1
-
100%
According to the 2021 annual accounts of Practimed and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
8 current directorsThe network starts from this company’s directors. Other companies they run appear here as nodes.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
04-07
NBB filing
Annual accounts filed
financial year 2025 · full format
15-01
Gazette deed
Appointment: Frederik RAEMDONCK (gedelegeerde voor het dagelijks bestuur)2 facts ▸
Gazette deed
Appointment: Frederik RAEMDONCK (gedelegeerde voor het dagelijks bestuur)
2 facts ▸
- Board meeting, 16-12-2025
- Director appointment, Frederik RAEMDONCK (gedelegeerde voor het dagelijks bestuur)
2025
22-12
Gazette deed
Capital & shares · Amendment of the articlesCapital increase · Capital decrease · Authorised capital5 facts ▸
Gazette deed
Capital & shares · Amendment of the articles
Capital increase · Capital decrease · Authorised capital5 facts ▸
- Board meeting, 17-12-2025
- Capital increase, €548,545
- Capital decrease, €80,290
- Amendment of the articles, 5
- Authorised capital, “used, voor de derde maal” (deed in Dutch)
21-10
Gazette deed
Capital & shares · Resignations & appointmentsPower of attorney5 facts ▸
Gazette deed
Capital & shares · Resignations & appointments
Power of attorney5 facts ▸
- Board meeting, 09-09-2025
- Power of attorney, Frederik RAEMDONCK (3 times)
- Power of attorney, Stefanie GIELEN (3 times)
- Power of attorney, Daisy Swijns
- Power of attorney, Evy Vanzeir
18-08
Gazette deed
Resignations: Dr.Ans Mentens, Dr.Lies Vanderperre and 2 othersAppointments: Dr.Georges-Philippe Claes, Dr.Tom Germeys and 6 others16 facts ▸
Gazette deed
Resignations: Dr.Ans Mentens, Dr.Lies Vanderperre and 2 others
Appointments: Dr.Georges-Philippe Claes, Dr.Tom Germeys and 6 others16 facts ▸
- General meeting, 06-06-2025
- Director resignation, Dr.Ans Mentens (director)
- Director resignation, Dr.Lies Vanderperre (director)
- Director resignation, Dr.Jean Boelanders (director)
- Director resignation, Dr.Els Demoitié (director)
- Director appointment, Dr.Georges-Philippe Claes (director)
- Director appointment, Dr.Tom Germeys (director)
- Director appointment, Dr.Benoit Gielen (director)
- Director appointment, Dr.Ben Janssen (director)
- Director appointment, Dr.IIs Laeveren (director)
- Director appointment, Dr.Daisy Timmermans (director)
- Director appointment, Dr.Joyce Van Hoeck (director)
- +4 further facts in this act
30-06
NBB filing
Annual accounts filed
financial year 2024 · full format
02-06
Gazette deed
Appointment: Figurad Bedrijfsrevisoren BV (statutory auditor)Permanent representative: Bart Meganck4 facts ▸
Gazette deed
Appointment: Figurad Bedrijfsrevisoren BV (statutory auditor)
Permanent representative: Bart Meganck4 facts ▸
- General meeting, 07-06-2024
- Auditor appointment, Figurad Bedrijfsrevisoren BV (statutory auditor)
- Permanent representative, Bart Meganck
- Other provision, “ondertekening en identificatie, Mededelingen” (deed in Dutch)
09-05
NBB filing
Annual accounts filed
financial year 2023 · full format · 282 days late
2024
24-12
Gazette deed
Capital & shares · Amendment of the articlesCapital increase · Capital decrease4 facts ▸
Gazette deed
Capital & shares · Amendment of the articles
Capital increase · Capital decrease4 facts ▸
- Board meeting, 19-12-2024
- Capital increase, €142,910
- Capital decrease, €308,388
- Amendment of the articles, 5
2023
22-12
Gazette deed
Amendment of the articlesAuthorised capital · Capital increase · Capital decrease5 facts ▸
Gazette deed
Amendment of the articles
Authorised capital · Capital increase · Capital decrease5 facts ▸
- Authorised capital, “used”, 27-04-2023 (deed in Dutch)
- Capital increase, €590,705
- Capital decrease, €162,750
- Amendment of the articles
- Amendment of the articles, “Artikel 5” (deed in Dutch)
26-05
NBB filing
Annual accounts filed
financial year 2022 · full format
2022
26-05
NBB filing
Annual accounts filed
financial year 2021 · full format
Show earlier events
2021
31-12
Financial
Highest result from 2018 to 2025net €5.3m ▲108%
Operating result €6.7m, net result €5.3m, both a record.
27-05
NBB filing
Annual accounts filed
financial year 2020 · full format
2020
26-05
NBB filing
Annual accounts filed
financial year 2019 · full format
2019
24-06
NBB filing
Annual accounts filed
financial year 2018 · full format
2018
09-08
NBB filing
Annual accounts filed
financial year 2017 · full format · 9 days late
2017
12-07
NBB filing
Annual accounts filed
financial year 2016 · full format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 49 annual accounts filed, the latest 10 are here; all 49 are under Financials.
7 of 20 deeds read
About the unread acts
Of the 20 Belgian Official Gazette deeds we know for this company, 7 have been read. The other 13 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Register details
Identification
Legal formPrivate limited company
Founded18-06-1965
Financial year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
86910Medical imaging and medical laboratories
86995Nutrition and dietetics services
E-invoicing
Reachable via Peppol
Peppol ID
0208:0401339577
Also
9925:BE0401339577
Registered
13-12-2024
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 21 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Recognitions · licences · registrations
Care and welfare
3 servicesPractimed campus Bree
Practimed campus Maasmechelen
Practimed campus Tessenderlo
Legal Entity Identifier
5493004GTHBM8HTWSN39
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
Location & real-estate footprint
Registered office, Tessenderlo-Ham · 4 establishment units since 2007
Ground area
2.0 ha
Building footprint
4,248 m²
Building volume
6,955 m³
4 parcels, Flanders · tallest building 11.8 m. Linked by address, not a title deed.
6
companies at this address
See who is registered here
4 establishment units
Practimed cv bvba
since 2007unit no. 2.165.532.225
Practimed cv bvba
since 2007unit no. 2.165.532.423
Practimed
since 2022unit no. 2.341.568.914
Practimed
since 2023unit no. 2.355.314.210
4 parcels
Flanders
4
(100%)
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 71363C0983/00D003 | Flanders | 6,874 m² | - | - |
| 72004B0971/00H000 | Flanders | 6,435 m² | 1 · 1,568 m² | - |
| 71362B0097/00F000 | Flanders | 6,366 m² | 1 · 1,801 m² | - |
| 73048C0215/00P000 | Flanders | 496 m² | 1 · 878 m² | 11.8 m · 3 |
How the parcels are linked
Good to know
All 4 parcels match the address exactly.